Drug Shortage Report for MYLAN-NIFEDIPINE EXTENDED RELEASE

Last updated on 2020-06-10 History
Report ID 104685
Drug Identification Number 02321149
Brand name MYLAN-NIFEDIPINE EXTENDED RELEASE
Common or Proper name NIFEDIPINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) NIFEDIPINE
Strength(s) 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100BT
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-01-20
Estimated end date 2020-07-07
Actual end date 2020-06-09
Shortage status Resolved
Updated date 2020-06-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-29 English Compare
v2 2020-01-29 French Compare
v3 2020-02-05 English Compare
v4 2020-02-05 French Compare
v5 2020-02-19 English Compare
v6 2020-02-19 French Compare
v7 2020-03-03 English Compare
v8 2020-03-03 French Compare
v9 2020-03-25 English Compare
v10 2020-03-25 French Compare
v11 2020-04-02 English Compare
v12 2020-04-02 French Compare
v13 2020-04-07 English Compare
v14 2020-04-07 French Compare
v15 2020-05-06 English Compare
v16 2020-05-06 French Compare
v17 2020-05-26 English Compare
v18 2020-05-26 French Compare
v19 2020-06-03 English Compare
v20 2020-06-03 French Compare

Showing 1 to 20 of 22